Loading
Latest filing published 03 Dec 2025 for NurExone Biologic Inc formerly, EnerSpar Corp, €109k. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
This profile gathers the share dealings of Yoram Drucker in NurExone Biologic Inc. (formerly, EnerSpar Corp.). We count 3 filings; the first trade dates from 15 June 2022 and the latest from 26 November 2025.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
The latest filing, published on 3 December 2025, reports a share grant of €109k in NurExone Biologic Inc. (formerly, EnerSpar Corp.). The median gap between a trade and its publication by SEDI is 7 days. The shorter that gap, the sooner other investors can see what insiders have done. Every figure here comes from the filings published by SEDI and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations